Skip to main content
Equibles

DAFNA Capital Management LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1389933 LOS ANGELES, CA
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,124,900
-$3,006,338 QoQ
Shares Held
2,008,164
-1.0% QoQ
Ownership
1.93%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#10
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. LRMR ranks #13 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in LRMR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,124,900 2,008,164
2026-03-31 $9,131,238 2,029,164
2025-12-31 $3,578,214 939,164
2025-09-30 $3,319,677 1,027,764
2025-06-30 $1,073,444 371,434
2025-03-31 $798,583 371,434
2024-12-31 $1,437,449 371,434
2024-09-30 $3,237,494 494,274
2024-06-30 $4,639,811 639,974
2024-03-31 $4,981,871 656,373
2023-12-31 $1,473,622 323,873
2023-09-30 $1,293,123 327,373
2023-06-30 $1,096,667 350,373
2023-03-31 $1,073,034 236,873
2022-12-31 $1,954,051 473,136
2022-09-30 $1,839,987 574,996
2022-06-30 $97,992 49,996
2022-03-31 $202,483 49,996
2021-12-31 $757,209 70,177
2021-09-30 $743,535 64,487
2021-06-30 $756,012 76,987
2021-03-31 $1,189,721 81,432
2020-12-31 $1,036,843 48,428
2020-09-30 $1,200,781 79,155
2020-06-30 $1,622,453 126,261